daily californian logo

BERKELEY'S NEWS • JUNE 03, 2023

Apply to The Daily Californian!
tag

Broad Institute

Page 1 of 2

The U.S. Patent Office ruled Monday that patents for some CRISPR technologies do not belong to the university and other partner institutions.
featured article
The U.S. Patent Office ruled Monday that patents for some CRISPR technologies do not belong to the university and other partner institutions.
featured article
The United States Patent and Trademark Office issued the UC system's 20th CRISPR-Cas9 gene-editing technology patent with the arrival of the new year, according to a press release by Berkeley News.
featured article
The United States Patent and Trademark Office issued the UC system's 20th CRISPR-Cas9 gene-editing technology patent with the arrival of the new year, according to a press release by Berkeley News.
featured article
The Patent Trial and Appeal Board of the U.S. Patent and Trademark Office announced an interference between multiple UC and multiple Broad Institute patents, a signal that the USPTO will resolve the seven-year ownership debate regarding CRISPR-Cas9 genome editing in eukaryotic cells.
featured article
The Patent Trial and Appeal Board of the U.S. Patent and Trademark Office announced an interference between multiple UC and multiple Broad Institute patents, a signal that the USPTO will resolve the seven-year ownership debate regarding CRISPR-Cas9 genome editing in eukaryotic cells.
featured article
On April 23, the U.S. Patent and Trademark Office issued UC Berkeley its fourth patent for CRISPR Cas-9, a revolutionary gene-editing technology.
featured article
On April 23, the U.S. Patent and Trademark Office issued UC Berkeley its fourth patent for CRISPR Cas-9, a revolutionary gene-editing technology.
featured article
After four years of litigation battles, the US Patent and Trademark Office, or USPTO, has finally approved a third CRISPR patent for the University of California.
featured article
After four years of litigation battles, the US Patent and Trademark Office, or USPTO, has finally approved a third CRISPR patent for the University of California.
featured article
The UC Board of Regents will convene at UCLA Meyer and Renee Luskin Conference Center from Tuesday through Thursday to discuss advocacy in state government, recent audits, court cases and policies about relations with Native American communities.
featured article
The UC Board of Regents will convene at UCLA Meyer and Renee Luskin Conference Center from Tuesday through Thursday to discuss advocacy in state government, recent audits, court cases and policies about relations with Native American communities.
featured article
The U.S. Court of Appeals for the Federal Circuit ultimately ruled that patents held for inventions by the Broad Institute, Harvard University and the Massachusetts Institute of Technology are distinct from the UC’s patents. The institutions have engaged in a long battle over the patents, which have the potential to secure both prestige and billions of dollars in licensing agreements.
featured article
The U.S. Court of Appeals for the Federal Circuit ultimately ruled that patents held for inventions by the Broad Institute, Harvard University and the Massachusetts Institute of Technology are distinct from the UC’s patents. The institutions have engaged in a long battle over the patents, which have the potential to secure both prestige and billions of dollars in licensing agreements.
featured article
The patent is based on the enzyme system CRISPR-Cas9, which was discovered in 2012 by Jennifer Doudna and Emmanuelle Charpentier.
featured article
The patent is based on the enzyme system CRISPR-Cas9, which was discovered in 2012 by Jennifer Doudna and Emmanuelle Charpentier.
featured article
CRISPR-Cas9, the gene-editing technology co-invented by a UC Berkeley professor, is again in the courts, as the University of California fights the Broad Institute, Harvard University and the Massachusetts Institute of Technology, or MIT, over patent rights that could yield billions.
featured article
CRISPR-Cas9, the gene-editing technology co-invented by a UC Berkeley professor, is again in the courts, as the University of California fights the Broad Institute, Harvard University and the Massachusetts Institute of Technology, or MIT, over patent rights that could yield billions.
featured article
The Broad Institute filed a brief Wednesday denying many of the University of California’s patent claims on CRISPR-Cas9, a groundbreaking gene editing technology.
featured article
The Broad Institute filed a brief Wednesday denying many of the University of California’s patent claims on CRISPR-Cas9, a groundbreaking gene editing technology.
featured article